14 - 15 May, 2019 | Hotel Novotel Amsterdam Schiphol Airport, Amsterdam, Netherlands
Conference Day One
9:20 am - 9:40 am Opening Keynote: A Global View of the Biosimilars Market
- Discuss the regionally variable challenges and opportunities that exist across the global biosimilars market
- Consider recent and historical trends with a view to explore the future of biosimilars on a global scale
- Join your colleagues in an open forum for discussion on how you can help drive the industry for mutual benefit
9:40 am - 10:10 am An Update on the Current Legal Landscape for Biosimilars in the US
- Deep-dive into the latest updates on biosimilars litigation
- Explore antitrust and unfair competition issues in biosimilar markets
- Discuss the effects of anti-substitution legislation at the state level on biosimilar uptake
10:10 am - 10:55 am Panel Discussion: Exploring the Sensitivity and Complexity of the North American Biosimilars Market
- Overcome the current battle to combat misinformation surrounding biosimilars in the US, and the essential methods to boost stakeholder confidence, in the face of immense competition from biologics
- Discuss the current regulatory landscape with respect to the FDA Biosimilar Action Plan and the newly published regulatory framework regarding the use of real world evidence and real world data
- Explore the game-changing concept of the ‘Purple Book’ for pharmacists, asking “Does this make either medical or commercial logic?”
10:55 am - 11:25 am Networking Coffee Break
11:25 am - 12:00 pm Case Study: Cracking the Canadian Market and Breaking into Brazil
- Explore the novel and low cost method of using plants in the development and manufacture of biosimilars
- Discover how PlantForm was able to maximise success in the conservative Canadian market and break into Brazil
- Looking to the future: prospects for PlantForm in China, India and South Africa, considering regulatory differences and market access strategy
12:00 pm - 12:35 pm Mexico and the Wider South American Market
- Discover how to navigate one of the largest and complex public health services in the world, with key takeaways to target your approach to world-wide payers
- Explore the access roadmap to 150 government public buyers, with a comprehensive study of timings and procedures
- Discuss the impact of biosimilars in emerging markets with example case-studies from Mexico, considering both market value and patient access
- Draw comparisons with principle countries of the LATAM region
12:35 pm - 1:35 pm Networking Lunch
1:35 pm - 2:05 pm Case Study: Discovering the Opportunities in the Chinese Market Place and Bridging the Gap to New Pharmerging Markets
- Consider the low penetration of biologic medicines and what this means for the prospective biosimilar market, in respect to unmet medical needs
- Volumes Game: Question why the Chinese market does not have the same fears for sustainability as other global market places
- Case Study: Moving between the Chinese, Taiwanese and Mexican market places
2:05 pm - 2:35 pm Case Study: Launching a Biosimilar into the European Marketplace in 2019
- Explore the current European market place by analysing the successes and failures of Big Pharma and SMEs in their approach to biosimilar commercialisation
- Benchmark your branding practice and commercial strategy against the challenges and opportunities encountered in the preparation for launch of a new biosimilar
- Get a sneak peek into pre-marketing and marketing activities around a launch of a new biosimilar into the European market
2:35 pm - 3:05 pm Networking Coffee Break
3:05 pm - 3:35 pm Miracle Market? A Discussion of the Danish Market Place
- Explore the successful market penetration of biosimilars into Denmark, with consideration of the tendering system, high uptake and low prices
- Uncover what role the patients, health authorities and physicians had in the biosimilar uptake
- The future of the Danish market place: a discussion on sustainability and lessons learned
3:35 pm - 4:10 pm The Four Pillars Supporting Biosimilar Uptake in Spain
- Discover the nuances of the Spanish biosimilar market and the barriers that have historically limited uptake
- Explore how Biogen have built up opportunities in the Spanish market and resolved difficulties
- Develop and execute a clear strategy to overcome the challenges associated with payers, prescribers and price in Spain
4:10 pm - 4:40 pm Networking Coffee Break
4:40 pm - 5:40 pm The Value and Trust Tool Kit
- Understand the cross-functional roles required to deliver a successful commercial launch
- Determine what 'value' is and what it means to different stakeholders
- Identify the requirements for successful partnerships with customers
- Decide whether price alone delivers success
- Deliver robust internal benchmarks and measures to qualify success
5:40 pm - 6:20 pm Panel Discussion: Boosting Patient Access to Biosimilars In Europe
- Explore the need for collaboration between Payers, Regulators and Industry to enhance patient access to biosimilars in Europe
- Consider how policy can be utilized as a tool to broaden patient access
- What does the future hold for the stability of the Biosimilars Market in the EU?
